Physical Activity in Dialysis: Clinical and Biological Impact
Launched by ELSAN · Aug 20, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a supervised physical activity program can impact patients with Chronic Renal Failure (CRF) who are undergoing hemodialysis. Researchers want to understand if regular exercise during dialysis sessions can improve the overall health and well-being of these patients, who are at higher risk for serious health issues due to inactivity. The goal is to see if exercise can help reduce problems like heart disease, depression, and loss of independence.
To be eligible for this study, participants must be at least 18 years old and currently receiving hemodialysis. They should be in good enough health to engage in physical activity safely during their dialysis sessions. Important exclusions include those who have recently had a heart attack or certain conditions that prevent them from participating in the exercise. If someone joins the study, they can expect to take part in a structured exercise program while receiving their usual dialysis treatment, contributing to valuable research that could improve care for patients with CRF.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female aged 18 or over.
- • Patient on hemodialysis.
- • Patient in sufficient clinical condition allowing performing physical activity sessions during dialysis, according to the judgment of the investigator.
- • Patient who was informed of the study and who gave his informed consent.
- • Patient benefiting from a mandatory social security.
- Exclusion Criteria:
- • Recent myocardial infarction (\<1 month).
- • Rheumatological pathology which does not allow pedaling.
- • Unmatched amputation of the lower limbs.
- • Patients under legal protection.
- • Pregnant or breastfeeding women.
About Elsan
Elsan is a leading healthcare organization specializing in the management and operation of private medical facilities, with a strong focus on enhancing patient care and clinical outcomes. With a commitment to innovation and excellence, Elsan conducts clinical trials that advance medical research and treatment options across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and researchers to ensure rigorous study design and ethical standards, ultimately aiming to contribute valuable insights to the medical community and improve patient health on a broader scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ollioules, , France
Marseille, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials